Activation of PPARα prevents lipid accumulation and inflammation in the liver by depressing the activation of pro-inflammatory macrophages, which ultimately leads to the reversal of typical NASH histological characteristics. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.